Huys I - Search Results

1

Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians.

Barbier L, Vandenplas Y, Simoens S, Declerck P, Vulto AG, Huys I. Barbier L, et al. Among authors: huys i. J Pharm Policy Pract. 2021 Jun 22;14(1):53. doi: 10.1186/s40545-021-00330-x. J Pharm Policy Pract. 2021. PMID: 34158128 Free PMC article.

2

Biosimilars and market access: a question of comparability and costs?

Simoens S, Verbeken G, Huys I. Simoens S, et al. Among authors: huys i. Target Oncol. 2012 Dec;7(4):227-31. doi: 10.1007/s11523-011-0192-7. Epub 2012 Jan 17. Target Oncol. 2012. PMID: 22249657 Review.

3

Market entry of biosimilar low-molecular-weight heparins in Europe: opportunities and challenges.

Simoens S, Huys I. Simoens S, et al. Among authors: huys i. Semin Thromb Hemost. 2013 Apr;39(3):250-7. doi: 10.1055/s-0032-1328970. Epub 2012 Dec 12. Semin Thromb Hemost. 2013. PMID: 23235959

4

European drug shortages: a call for action!

Huys I, Simoens S. Huys I, et al. Int J Pharm Pract. 2013 Feb;21(1):1-2. doi: 10.1111/ijpp.12012. Int J Pharm Pract. 2013. PMID: 23301528 No abstract available.

5

Market access of cancer drugs in European countries: improving resource allocation.

Pauwels K, Huys I, Casteels M, De Nys K, Simoens S. Pauwels K, et al. Among authors: huys i. Target Oncol. 2014 Jun;9(2):95-110. doi: 10.1007/s11523-013-0301-x. Epub 2013 Nov 19. Target Oncol. 2014. PMID: 24243526 Review.

6

Drug shortages in European countries: a trade-off between market attractiveness and cost containment?

Pauwels K, Huys I, Casteels M, Simoens S. Pauwels K, et al. Among authors: huys i. BMC Health Serv Res. 2014 Sep 26;14:438. doi: 10.1186/1472-6963-14-438. BMC Health Serv Res. 2014. PMID: 25257912 Free PMC article.

7

Causes of drug shortages in the legal pharmaceutical framework.

De Weerdt E, Simoens S, Hombroeckx L, Casteels M, Huys I. De Weerdt E, et al. Among authors: huys i. Regul Toxicol Pharmacol. 2015 Mar;71(2):251-8. doi: 10.1016/j.yrtph.2015.01.005. Epub 2015 Jan 12. Regul Toxicol Pharmacol. 2015. PMID: 25591547

8

Insights into European drug shortages: a survey of hospital pharmacists.

Pauwels K, Simoens S, Casteels M, Huys I. Pauwels K, et al. Among authors: huys i. PLoS One. 2015 Mar 16;10(3):e0119322. doi: 10.1371/journal.pone.0119322. eCollection 2015. PLoS One. 2015. PMID: 25775406 Free PMC article.

9

Predictors for reimbursement of oncology drugs in Belgium between 2002 and 2013.

Pauwels K, Huys I, De Nys K, Casteels M, Simoens S. Pauwels K, et al. Among authors: huys i. Expert Rev Pharmacoecon Outcomes Res. 2015;15(5):859-68. doi: 10.1586/14737167.2015.1047347. Epub 2015 May 15. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 25978862

10

Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium.

Bauters T, Claus BO, Norga K, Huys I, Simoens S, Laureys G. Bauters T, et al. Among authors: huys i. J Oncol Pharm Pract. 2016 Dec;22(6):766-770. doi: 10.1177/1078155215610915. Epub 2015 Oct 6. J Oncol Pharm Pract. 2016. PMID: 26447099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters